Article · 2015
Editorial Board Member
Fazlul H Sarkar
Professor, Departments of Pathology and Oncology, Wayne State University, USA
About
As published by the journal they serve.
Dr. Sarkar is currently a Distinguished Professor, Departments of Pathology and Oncology at Karmanos Cancer Institute, Wayne State University School of Medicine. Dr. Sarkar’s early research, which still continues, is focused on understanding the role of a “master” transcription factor and the regulation of its upstream and downstream signaling molecules in solid tumors, and focusing on tumor microenvironment. Moreover, his research has been directed toward elucidating the molecular mechanism(s) of action of “natural agents”, their synthetic analogues, and other synthetic small molecule inhibitors of Bcl-2 and MDM2 for cancer prevention and therapy. The discoveries from in vitro and in vivo preclinical studies led to the design and execution of multiple Phase I/II clinical trials in breast, pancreas and prostate cancer for assessing the effects of several “natural agents” in the alterations of biomarkers as well as some early clinical efficacy testing. Dr. Sarkar’s research led to the concept of chemo-sensitization of cancer cells by reversing their drug-resistance phenotype to conventional therapeutics (chemo-radio-therapy), and all of which has been focused on tumor microenvironment, which led to clinical trials conducted at the Karmanos Cancer Institute. The innovation of his basic science research has attracted clinicians to collaborate with him, which clearly documents his leadership in translational research. Dr. Sarkar’s collaborations with basic scientists and physician scientists at MD Anderson Cancer Center led him to become a project leader for the Pancreas Cancer SPORE grant of MD Anderson Cancer Center under the leadership of Dr. James Abbruzzese, and Dr. Sarkar also served as a co-investigator for the University of Michigan Head and Neck Cancer SPORE grant.
Research interests
Journals they serve
The seats these journals name them in.
- Pancreatic Disorders & TherapyEditorial Board Member
Articles we hold
Articles in the journals they serve whose byline carries this name.
Article · 2013
Notch Signaling Pathway in Pancreatic Cancer Progression
Article · 2012
Emerging Role of MicroRNA in Pancreatic Cancer
Article · 2012
The Role of EMT in Pancreatic Cancer Progression
Article · 2012
Identifying Biomarkers and Drug Targets Using Systems Biology Approaches for Pancreatic Cancer
Article · 2016
MicroRNAs: Biomarkers and therapeutic targets in drug resistant pancreatic cancer
Article · 2016
Exploiting the role of exosomes and microRNAs (miRNAs) for pancreatic cancer therapy
Article · 2016
A novel approach for overcoming drug resistance in gastrointestinal cancers
Article · 2016
Mechanistic role of BR-DIM in human prostate cancer: Clinical experience
Article · 2015
Comparative Analysis of Differentially Expressed miRNAs and their Downstream mRNAs in Ovarian Cancer and its Associated Endometriosis
Article · 2015
Differential Expression of MicroRNAs in Papillary Thyroid Carcinoma and Their Role in Racial Disparity
Article · 2015
Differential Expression of MicroRNAs in Tissues and Plasma Co-exists as a Biomarker for Pancreatic Cancer
Article · 2015
Identification of Differentially Expressed MiRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma
Article · 2013
Cancer Stem Cells: Coming of Age
Article · 2013
Systems and Network Pharmacology Approaches to Cancer Stem Cells Research and Therapy
Article · 2013
Lung Cancer Stem Cells: Current Progress and Future Perspectives
Article · 2013
The Role of Cancer Stem Cells and MicroRNAs in the Development and Progression of Pancreatic Cancer
Article · 2012
Evolving Concept of Cancer Stem Cells: Role of Micro-RNAs and their Implications in Tumor Aggressiveness
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.
